Syndax Pharma (SNDX)
13.00 x 7 13.98 x 3
Post-market by (Cboe BZX)
13.18 -0.38 (-2.80%) 03/28/25 [NASDAQ]
13.00 x 7 13.98 x 3
Post-market 13.14 -0.04 (-0.30%) 18:36 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 23,680 | 0 | 0 | 139,709 | 1,517 |
| Cost of Goods | 826 | N/A | N/A | N/A | N/A |
| Gross Profit | 22,854 | N/A | N/A | 139,709 | 1,517 |
| Operating Expenses | 363,352 | 229,954 | 151,757 | 113,489 | 72,940 |
| Operating Income | -339,672 | -229,954 | -151,757 | 26,220 | -71,423 |
| Interest Expense | 4,929 | 208 | 3,137 | 1,899 | 2,357 |
| Other Income | 25,843 | 20,802 | 5,556 | 605 | 622 |
| Pre-tax Income | -318,758 | -209,360 | -149,338 | 24,926 | -73,158 |
| Net Income Continuous | -318,758 | -209,360 | -149,338 | 24,926 | -73,158 |
| Net Income | $-318,758 | $-209,360 | $-149,338 | $24,926 | $-73,158 |
| EPS Basic Total Ops | -3.72 | -2.98 | -2.46 | 0.48 | -1.87 |
| EPS Basic Continuous Ops | -3.72 | -2.98 | -2.46 | 0.48 | -1.77 |
| EPS Diluted Total Ops | -3.72 | -2.98 | -2.46 | 0.46 | -1.87 |
| EPS Diluted Continuous Ops | -3.72 | -2.98 | -2.46 | 0.46 | -1.77 |
| EPS Diluted Before Non-Recurring Items | -3.72 | -2.98 | -2.46 | 0.48 | -1.87 |
| EBITDA(a) | $-353,102 | $-244,745 | $-155,106 | $26,907 | $-71,464 |